Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP730083.RAUVfd0BfUP2qPIbuRprEJpzm-wQe72aO3dkd8o4K-jos130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP730083.RAUVfd0BfUP2qPIbuRprEJpzm-wQe72aO3dkd8o4K-jos130_assertion type Assertion NP730083.RAUVfd0BfUP2qPIbuRprEJpzm-wQe72aO3dkd8o4K-jos130_head.
- NP730083.RAUVfd0BfUP2qPIbuRprEJpzm-wQe72aO3dkd8o4K-jos130_assertion wasGeneratedBy ECO_0000203 NP730083.RAUVfd0BfUP2qPIbuRprEJpzm-wQe72aO3dkd8o4K-jos130_provenance.
- NP730083.RAUVfd0BfUP2qPIbuRprEJpzm-wQe72aO3dkd8o4K-jos130_assertion wasDerivedFrom befree-2016 NP730083.RAUVfd0BfUP2qPIbuRprEJpzm-wQe72aO3dkd8o4K-jos130_provenance.
- NP730083.RAUVfd0BfUP2qPIbuRprEJpzm-wQe72aO3dkd8o4K-jos130_assertion SIO_000772 19340428 NP730083.RAUVfd0BfUP2qPIbuRprEJpzm-wQe72aO3dkd8o4K-jos130_provenance.
- NP730083.RAUVfd0BfUP2qPIbuRprEJpzm-wQe72aO3dkd8o4K-jos130_assertion evidence source_evidence_literature NP730083.RAUVfd0BfUP2qPIbuRprEJpzm-wQe72aO3dkd8o4K-jos130_provenance.
- NP730083.RAUVfd0BfUP2qPIbuRprEJpzm-wQe72aO3dkd8o4K-jos130_assertion description "[IGHV gene mutational status and LPL/ADAM29 gene expression as clinical outcome predictors in CLL patients in remission following treatment with oral fludarabine plus cyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP730083.RAUVfd0BfUP2qPIbuRprEJpzm-wQe72aO3dkd8o4K-jos130_provenance.